Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
about
Nanomedicine: promises and challenges for the future of public healthNasal vaccine innovation.The impact of nanoparticle ligand density on dendritic-cell targeted vaccines.Vaccine delivery using nanoparticles.Vaccine adjuvants - Current status and prospects on controlled release adjuvancity.Designing polymeric particles for antigen delivery.Peptide/protein vaccine delivery system based on PLGA particles.The long-term potential of biodegradable poly(lactide-co-glycolide) microparticles as the next-generation vaccine adjuvant.Advances in effective vaccine development against hepatitis B: focus on mucosal vaccine delivery strategies.Recent advances in polymeric microspheres for parenteral drug delivery--part 1.Next generation vaccines: single-dose encapsulated vaccines for improved global immunisation coverage and efficacy.Toward a Single-Dose Vaccination Strategy with Self-Encapsulating PLGA Microspheres.PLGA based drug delivery systems: Promising carriers for wound healing activity.Recent advances in testing of microsphere drug delivery systems.Preparation, characterization and immunological evaluation: canine parvovirus synthetic peptide loaded PLGA nanoparticles.Preparation and characteristics of interferon-alpha poly(lactic-co-glycolic acid) microspheres.A systems approach to designing next generation vaccines: combining α-galactose modified antigens with nanoparticle platforms.Design and evaluation of D-α tocopheryl polyethylene glycol 1000 succinate emulsified poly-ϵ-caprolactone nanoparticles for protein/peptide drug delivery."Prevention of structural perturbation and aggregation of hepatitis B surface antigen: screening of various additives".Preparation and evaluation of double-walled microparticles prepared with a modified water-in-oil-in-oil-in-water (w1/o/o/w3) method.Humoral and cell-mediated immune-responses after administration of a single-shot recombinant hepatitis B surface antigen vaccine formulated with cationic poly(l-lactide) microspheres.Spray-dried chitosan microparticles for cellular delivery of an antigenic protein: physico-chemical properties and cellular uptake by dendritic cells and macrophages.Enhancement of immune response of HBsAg loaded poly (L-lactic acid) microspheres against hepatitis B through incorporation of alum and chitosan.Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination.
P2860
Q28384103-8AC0E527-987A-4479-AA56-4CC3FD742F0CQ30395810-AFB96CE3-A9B4-40A6-B32F-886DDD80D40FQ36062758-7FEBD98A-0091-4E12-B579-73832D0E15ADQ36712817-2471CC5C-C064-499C-80D4-31215853D897Q37098801-C9E20950-390A-4F37-8255-A2D14BE99A75Q37808118-55B815AA-3396-4378-AE74-F6521CAE0897Q37838652-B961C37B-FA01-4C76-9F9F-BF871E8955D0Q37956385-F0F356DA-DA4E-4BE8-BE17-11B7ED3C7624Q38027857-48FF5172-891E-4DD0-8698-3C087562C9C9Q38029806-A20F8848-1D4D-4622-8C6D-AEE3CE828A33Q38341522-0F5425C9-2EEE-4F9C-820B-05EE9F5E4FC1Q38404208-41FA78DA-9BAB-4C90-A44A-80345D9AD3DBQ38691458-326481BE-C585-4336-8F0C-28BD5035FC4BQ38717509-365BC96B-7C62-46BC-BDB1-0B600CB60AA2Q38826606-DF8F925F-75C0-4A88-A45D-46C9E718BDDBQ39745479-369EE569-92D7-449E-8CD1-B5BEF8EA4858Q41879397-CA30EDA8-D110-4A03-A052-019031A06A40Q43617316-C90FE436-D393-4ABF-9546-07F47B2A82F1Q44989827-033E20A1-47AD-4A01-97DC-BBD8B12C4137Q45377241-C3C88E58-13CF-42BD-AA46-74B26504059DQ45803020-AD393EF8-C4DF-45D9-A838-F1AED5DB10B2Q46930554-97CCB624-3810-4878-9278-AFE3DEBF3840Q50951051-1019C3F5-10E7-43FB-B749-06FF88BE708BQ55175110-25B6E062-4540-4229-81A2-1E2805AF8AED
P2860
Pharmaceutical and immunological evaluation of a single-dose hepatitis B vaccine using PLGA microspheres.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pharmaceutical and immunologic ...... ccine using PLGA microspheres.
@en
Pharmaceutical and immunologic ...... ccine using PLGA microspheres.
@nl
type
label
Pharmaceutical and immunologic ...... ccine using PLGA microspheres.
@en
Pharmaceutical and immunologic ...... ccine using PLGA microspheres.
@nl
prefLabel
Pharmaceutical and immunologic ...... ccine using PLGA microspheres.
@en
Pharmaceutical and immunologic ...... ccine using PLGA microspheres.
@nl
P2093
P1476
Pharmaceutical and immunologic ...... accine using PLGA microspheres
@en
P2093
Shi Cong Wang
Tsuneji Nagai
Xing Jun Zhou
Yang Jiang
Yoshie Maitani
P356
10.1016/J.JCONREL.2006.01.012
P407
P50
P577
2006-03-06T00:00:00Z